NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis
Authors
Keywords
-
Journal
Evidence-based Complementary and Alternative Medicine
Volume 2020, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2020-04-01
DOI
10.1155/2020/1561342
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nucleolin promotes Ang II‐induced phenotypic transformation of vascular smooth muscle cells by regulating EGF and PDGF‐BB
- (2020) Li Fang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway
- (2019) Yan Jiang et al. JOURNAL OF DRUG TARGETING
- Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A
- (2019) Lei Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The NLRP3 inflammasome in acute myocardial infarction
- (2019) Adolfo Gabriele Mauro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
- (2019) Humayun Sharif et al. NATURE
- P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis
- (2019) Juan José Martínez-García et al. Nature Communications
- Decreased M1 macrophage polarization in dabigatran-treated Ldlr-deficient mice: Implications for atherosclerosis and adipose tissue inflammation
- (2019) Kathrin Feldmann et al. ATHEROSCLEROSIS
- Dietary apigenin reduces induction of LOX-1 and NLRP3 expression, leukocyte adhesion and acetylated low-density lipoprotein uptake in human endothelial cells exposed to trimethylamine-N-oxide
- (2019) Kazuo Yamagata et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
- (2019) Lieselotte Vande Walle et al. PLOS BIOLOGY
- Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE−/− mice
- (2019) Ge Tang et al. BIOMEDICINE & PHARMACOTHERAPY
- ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis
- (2019) Xinnong Chen et al. Oxidative Medicine and Cellular Longevity
- MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE−/− mice
- (2019) Ruihua Yin et al. Annals of Palliative Medicine
- Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease
- (2019) Fumiya Anzai et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Inhibitory effects of colchicine on inflammasomes
- (2018) Florian Hoss et al. ATHEROSCLEROSIS
- The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation
- (2018) Gonzalo J. Martínez et al. ATHEROSCLEROSIS
- Inhibition of the NLRP3 inflammasome attenuates foam cell formation of THP-1 macrophages by suppressing ox-LDL uptake and promoting cholesterol efflux
- (2018) Liang Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cereal Fiber Ameliorates High-Fat/Cholesterol-Diet-Induced Atherosclerosis by Modulating the NLRP3 Inflammasome Pathway in ApoE–/– Mice
- (2018) Ru Zhang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals
- (2018) Anna J. Boland et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis
- (2018) Xianxian Wu et al. Cell Death & Disease
- Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy
- (2018) Shi Peng et al. Frontiers in Pharmacology
- Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis
- (2018) Yachun Han et al. Redox Biology
- MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis
- (2018) Peng Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of NLRP-3 Inflammasome in Hypertension: a Potential Therapeutic Target
- (2018) Teresa Pasqua et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Rosmarinic acid inhibits nicotine-induced C-reactive protein generation by inhibiting NLRP3 inflammasome activation in smooth muscle cells
- (2018) Yang Yao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The role of mitochondria in NLRP3 inflammasome activation
- (2018) Qiuyun Liu et al. MOLECULAR IMMUNOLOGY
- Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition
- (2018) Sai Ma et al. Oxidative Medicine and Cellular Longevity
- Generation of Vascular Endothelial Cells and Hematopoietic Cells by Blastocyst Complementation
- (2018) Sanae Hamanaka et al. Stem Cell Reports
- Monocyte-Macrophages and T Cells in Atherosclerosis
- (2017) Ira Tabas et al. IMMUNITY
- Human NACHT, LRR, and PYD domain–containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase
- (2017) Xiao Liu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
- (2017) Zahra Hoseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy
- (2017) Lulu Shen et al. JOURNAL OF LIPID RESEARCH
- POP1 might be recruiting its type-Ia interface for NLRP3-mediated PYD-PYD interaction: Insights from MD simulation
- (2017) Jitendra Maharana et al. JOURNAL OF MOLECULAR RECOGNITION
- Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis
- (2017) Yong Zhang et al. JOURNAL OF PINEAL RESEARCH
- Interleukin-1 Beta as a Target for Atherosclerosis Therapy
- (2017) Peter Libby JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
- (2017) Renqing Wang et al. LABORATORY INVESTIGATION
- The Synthetic Lignan Secoisolariciresinol Diglucoside Prevents Asbestos-Induced NLRP3 Inflammasome Activation in Murine Macrophages
- (2017) Ralph A. Pietrofesa et al. Oxidative Medicine and Cellular Longevity
- Inflammation in atherosclerosis
- (2016) Soraya Taleb Archives of Cardiovascular Diseases
- Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice
- (2016) Niklas Bode et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes
- (2016) Fanqi Kong et al. BIOMEDICINE & PHARMACOTHERAPY
- Vascular Smooth Muscle Cells in Atherosclerosis
- (2016) Martin R. Bennett et al. CIRCULATION RESEARCH
- Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
- (2016) Michael A. Gimbrone et al. CIRCULATION RESEARCH
- Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation
- (2016) S. Robertson et al. CLINICAL SCIENCE
- Why Calcium? How Calcium Became the Best Communicator
- (2016) Ernesto Carafoli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice
- (2016) Weiling Leng et al. MEDIATORS OF INFLAMMATION
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury
- (2016) Letteria Minutoli et al. Oxidative Medicine and Cellular Longevity
- NOD-Like Receptors in Infection, Immunity, and Diseases
- (2016) Young Keun Kim et al. YONSEI MEDICAL JOURNAL
- Curcumin Represses NLRP3 Inflammasome Activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-Induced Macrophages
- (2016) Fanqi Kong et al. Frontiers in Pharmacology
- Early Hyperlipidemia Promotes Endothelial Activation via a Caspase-1-Sirtuin 1 PathwaySignificance
- (2015) Ying Yin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- ER stress: Autophagy induction, inhibition and selection
- (2015) Harun-Or Rashid et al. Autophagy
- Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer
- (2015) Si Ming Man et al. CELL
- Response to Letter Regarding Article, “Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet”
- (2015) Amna Abderrazak et al. CIRCULATION
- Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development inLdlr−/−mice
- (2015) Tim Hendrikx et al. FEBS Journal
- Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
- (2015) Altaf Afrasyab et al. HEART AND VESSELS
- The Importance of NLRP3 Inflammasome in Heart Failure
- (2015) Brittany Butts et al. JOURNAL OF CARDIAC FAILURE
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxin-interacting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells
- (2015) Junna Song et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- Procyanidin B2 inhibits NLRP3 inflammasome activation in human vascular endothelial cells
- (2014) Haixia Yang et al. BIOCHEMICAL PHARMACOLOGY
- NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
- (2014) Masafumi Takahashi International Heart Journal
- The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation
- (2014) Masahiro Okada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysosomes Integrate Metabolic-Inflammatory Cross-talk in Primary Macrophage Inflammasome Activation
- (2014) Kassandra Weber et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RNA and β-Hemolysin of Group BStreptococcusInduce Interleukin-1β (IL-1β) by Activating NLRP3 Inflammasomes in Mouse Macrophages
- (2014) Rahul Gupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome
- (2014) M. Kool et al. JOURNAL OF IMMUNOLOGY
- Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
- (2014) Fei Zheng et al. MEDIATORS OF INFLAMMATION
- Reactive oxygen species at the crossroads of inflammasome and inflammation
- (2014) Anantha Harijith et al. Frontiers in Physiology
- Cardiolipin and the Nlrp3 Inflammasome
- (2013) Luke A.J. O’Neill Cell Metabolism
- Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility
- (2013) Han Xiao et al. CIRCULATION
- NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
- (2013) Fei Zheng et al. Heart Lung and Circulation
- Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
- (2013) Shankar S. Iyer et al. IMMUNITY
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification
- (2013) Chaoyang Wen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
- (2013) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- TRPM2 links oxidative stress to NLRP3 inflammasome activation
- (2013) Zhenyu Zhong et al. Nature Communications
- Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice
- (2012) Fumitake Usui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
- (2012) Jessica Gage et al. CANADIAN JOURNAL OF CARDIOLOGY
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
- (2012) Kenichi Shimada et al. IMMUNITY
- Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion
- (2012) Shrikant R. Mulay et al. JOURNAL OF CLINICAL INVESTIGATION
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout
- (2011) Flávio A. Amaral et al. ARTHRITIS AND RHEUMATISM
- Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
- (2011) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- The role of the NLRP3 Inflammasome in the pathogenesis of airway disease
- (2011) Mark A. Birrell et al. PHARMACOLOGY & THERAPEUTICS
- Endoplasmic-Reticulum Calcium Depletion and Disease
- (2011) D. Mekahli et al. Cold Spring Harbor Perspectives in Biology
- Sodium Overload and Water Influx Activate the NALP3 Inflammasome
- (2010) Christine Schorn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
- (2010) Kiichi Nakahira et al. NATURE IMMUNOLOGY
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
- (2010) Kristiina Rajamäki et al. PLoS One
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
- (2010) K. Schroder et al. SCIENCE
- Cutting Edge: TNF- Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation
- (2009) L. Franchi et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Cholesterol-dependent cytolysins induce rapid release of mature IL-1β from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner
- (2009) Jessica Chu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Monocyte-Endothelial Cell Interactions in the Development of Atherosclerosis
- (2009) Javier Mestas et al. TRENDS IN CARDIOVASCULAR MEDICINE
- CXCL16/SR-PSOX—A friend or a foe in atherosclerosis?
- (2008) Yuri Sheikine et al. ATHEROSCLEROSIS
- Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
- (2008) Alexandra-Chloé Villani et al. NATURE GENETICS
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- The NALP3 inflammasome is involved in the innate immune response to amyloid-β
- (2008) Annett Halle et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started